Sunday, February 05, 2012
abstract: Importance of Histologic Subtype in the Staging of Appendiceal Tumors
Blogger's Note: appendiceal cancer (cancer of the appendix) is not the only cancer where cell type histologic records are deficient eg. breast cancer; why it's important? many reasons: patients with dual malignancies, primary vs metastatic, borderline/invasive.....; as in ovarian cancer cell, type/s are included in one's own individual pathology report/s
Abstract
Background
Malignant neoplasms of the appendix have different behavior based on their histologic subtypes in anecdotal series. Current staging systems do not capture the diversity of histologic subtypes in predicting outcomes.
She the People - Komen, go back to your roots By Donna Trussell (author/ovarian cancer survivor) (including public comments)
"...... There is a school of thought that when charity founders retire or die, the organizations should die with them. The original mission gets lost amid the everyday tasks of promoting a brand, delivering services, and managing employees.......What did surprise me about Susan Komen’s story was how similar cancer experiences are. When you have a less publicized form of cancer, you tend to notice the boundaries between cancers, and the unequal allocation of resources......."
Australia - Cancer Directory - Lynch Syndrome booklet (pdf file - updated Jan 25, 2012)
Understanding genetic tests for Lynch syndrome. Information and decision aid
Year first published or reviewed: 2010
Last updated on: 25-01-2012
By: Centre for Genetics Education
Lynch syndrome cancers
People affected by Lynch syndrome have a higher risk of bowel cancer
and some other cancers listed in the table below.
Men with Lynch syndrome are at
high risk of developing:
large bowel cancer
Women with Lynch syndrome are
at high risk of developing:
large bowel cancer
endometrial cancer
ovarian cancer
Men and women have an
increased risk of developing:
cancers of the stomach, small
bowel, kidney, brain, pancreas,
ureter (tube from kidney to
bladder
abstract: Comparability of cancer identification among death registry, cancer registry and hospital discharge registry - International Journal of Cancer
Abstract
Registry based cancer incidence and mortality data are widely used for etiologic research, cancer control and health care monitoring and planning. The complete coverage of all cases is the key criteria of data quality but it is difficult to assess because the alternative sources of data may be flawed. ..........
..........In conclusion, some 10% of cancer deaths had no cancer records in CR (cancer registry) or in HDR (hospital discharge registry), and 3.4% were missing in both sources. The identification rate depended on tumor site, age at death, and, to some extent, death outside hospital.
..........In conclusion, some 10% of cancer deaths had no cancer records in CR (cancer registry) or in HDR (hospital discharge registry), and 3.4% were missing in both sources. The identification rate depended on tumor site, age at death, and, to some extent, death outside hospital.
Subscribe to:
Posts
(
Atom
)
Posts
